Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Lazertinib

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Lazcluze (lazertinib) is an oral prescription tablet medication classified as a kinase inhibitor. It is available in 80mg and 240mg strengths and is manufactured by Janssen Biotech, Inc. for treating specific conditions like certain cancers. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Lazertinib

    Access the FDA dataset for Lazertinib — ANDA 219008 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov